AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,109 | -12.5% | 44,805 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,268 | +17.5% | 44,783 | -4.7% | 0.00% | 0.0% |
| Q1 2023 | $1,079 | -18.2% | 46,979 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,319 | -99.9% | 46,979 | -1.2% | 0.00% | -25.0% |
| Q3 2022 | $1,344,000 | -41.3% | 47,543 | -54.0% | 0.00% | -33.3% |
| Q2 2022 | $2,291,000 | -84.9% | 103,319 | -70.5% | 0.01% | -82.9% |
| Q4 2020 | $15,199,000 | +64.5% | 350,768 | +32.9% | 0.04% | +40.0% |
| Q3 2020 | $9,238,000 | -36.3% | 263,939 | -2.6% | 0.02% | -41.9% |
| Q2 2020 | $14,496,000 | +51.5% | 271,058 | +0.5% | 0.04% | +26.5% |
| Q1 2020 | $9,568,000 | -25.4% | 269,671 | +0.3% | 0.03% | -8.1% |
| Q4 2019 | $12,832,000 | +65.2% | 268,733 | +12.1% | 0.04% | +54.2% |
| Q3 2019 | $7,769,000 | – | 239,789 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |